China’s drug regulator clears mpox vaccine; to undergo clinical trial, ET HealthWorld

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

China’s ***** regulator clears mpox vaccine; to undergo clinical trial, ET HealthWorld

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Beijing: China’s top ***** regulator has cleared a mpox vaccine developed by local ***** firm Sinopharm for clinical trials which could be the country’s first experimental dose to battle the deadly ********. The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to play an important role in preventing and controlling mpox infections, the company said in a statement released on Monday afternoon.

There is currently no approved mpox vaccine in China. Globally, a few vaccines have been approved in the ******* States, Canada, the ********* Union, Japan and Russia.

In China, a vaccine candidate typically goes through three phases of clinical trials before gaining market approval.

The process can take years, even decades. However, the National Medical Products Administration, China’s top ***** regulator, has launched a number of accelerated or streamlined channels to facilitate applications of novel drugs and vaccines or those in urgent need, state-run China Daily reported on Tuesday.

According to the company, the new vaccine is a replication-deficient vaccine based on a strain called MVA.

The description is the same as Jynneos, the world’s first mpox vaccine approved by the Food and ***** Administration in the ******* States in 2019.

The World Health Organisation said on August 14 that the mpox outbreak in ******* constitutes a public health emergency of international concern – its highest form of alert.

Previously, in July 2022, the WHO declared a global emergency but then lifted it in May last year because of a sustained decline in international cases.

So far, more than 120 countries and regions across the world have reported more than 100,000 confirmed infections and 226 related deaths.

China reported its first imported case in September 2022 and the first domestic case in June last year.

By the end of July, the nation had reported 2,567 confirmed cases, according to the China Daily report.

• Published On Sep 11, 2024 at 06:31 AM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Download ETHealthworld App

• Get Realtime updates
• Save your favourite articles

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Scan to download App
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

This is the hidden content, please

• Sign In
• or
• Sign Up

#Chinas #***** #regulator #clears #mpox #vaccine #undergo #clinical #trial #HealthWorld

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up